Could a simple change in labor medication make birth safer for babies?
NCT ID NCT03991091
Summary
This study tested whether stopping the labor-inducing drug oxytocin once active labor begins could reduce health problems in newborns. It involved 2,459 women who were already receiving oxytocin early in labor. Researchers compared outcomes for mothers whose oxytocin was stopped at 6 cm dilation to those who continued receiving it as standard care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL MORBIDITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
hospital Cochin; port royal Maternity unit
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.